Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 8.86
+0.07 (0.80%)
May 8, 2026, 3:04 PM CST
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 14.77 billion as of May 8, 2026. Its market cap has increased by 12.93% in one year.
Market Cap
14.77B
Enterprise Value
13.30B
Revenue
2.56B
Ranking
n/a
PE Ratio
21.13
Stock Price
8.86
Market Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 14.77B, an increase of 251.12%. That is a compound annual growth rate of 7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.77B | -7.49% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jinyu Bio-technology | 16.49B |
| Mabwell (Shanghai) Bioscience | 15.10B |
| Inner Mongolia Furui Medical Science | 14.83B |
| Chengdu Olymvax Biopharmaceuticals | 14.22B |
| Chengzhi | 13.68B |
| Staidson (Beijing) BioPharmaceuticals | 13.34B |
| Tibet Cheezheng Tibetan Medicine | 13.10B |
| InventisBio | 12.80B |